R. Tahara

Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer

N. Choudhry, S. Tolaney, M. Najafzadeh, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

Diane D. Liu, G. Hortobagyi, N. Ibrahim, 2019, Cancer medicine.

Acute appendicitis secondary to metastatic carcinoma of the breast: Case report and review of the literature

Lauren L. Ritterhouse, E. Winer, N. Ramaiya, 2015 .

Bone Metastasis of Breast Cancer.

R. Theriault, N. Ueno, T. Brewer, 2019, Advances in experimental medicine and biology.

Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.

E. Winer, L. Trippa, W. Barry, 2019, Clinical breast cancer.

Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC)

P. Sorger, E. Winer, G. Shapiro, 2021 .

Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

P. Sorger, E. Winer, E. V. Van Allen, 2020, Clinical Cancer Research.